Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

The document from November 23, 2020, reports on three cases of Telogen Effluvium (TE), a form of hair loss, following severe SARS-CoV-2 infection in women. The onset of hair shedding occurred 36 to 75 days after infection. The authors propose that the infection may trigger TE, potentially through cytokine storms damaging hair matrix cells. They ruled out drug-induced TE from treatments like enoxaparin and tocilizumab. The study suggests that severe SARS-CoV-2 infection could be a trigger for TE and emphasizes the need for further research. Management included informing patients about the duration of hair loss and recommending supplements and topical treatments, with minoxidil used cautiously. The document also highlights the adaptation of clinical practices during the pandemic, such as teledermatology and enhanced hygiene during in-person visits.